PBMCs from patients with SJS and TEN secrete significant amounts of sFasL in the acute stage after stimulation with causal drugs, which subsequently induce keratinocyte apoptosis in a dose-dependent manner [8]. The gene discussed is FASLG; the disease is Schwartz-Jampel syndrome.